Pulmonx Corporation
General ticker "LUNG" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $169.0M (TTM average)
Pulmonx Corporation does not follow the US Stock Market performance with the rate: -29.0%.
Estimated limits based on current volatility of 5.1%: low 1.83$, high 2.02$
Factors to consider:
- Total employees count: 291 (+4.3%) as of 2024
- US accounted for 67.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Net losses, Manufacturing risks, IT security, Strategic risks and growth management, Geopolitical risks
- Current price 42.1% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.69$, 9.42$]
- 2025-12-31 to 2026-12-31 estimated range: [3.09$, 8.01$]
Financial Metrics affecting the LUNG estimates:
- Negative: with PPE of -4.5 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -12.58 <= 0.33
- Positive: Interest expense per share per price, % of 1.40 <= 3.41
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 6.97 > -0.66
- Positive: 41.86 < Shareholder equity ratio, % of 52.69 <= 63.39
- Positive: Inventory ratio change, % of -2.82 <= -0.75
Short-term LUNG quotes
Long-term LUNG plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $53.66MM | $68.67MM | $83.79MM |
| Operating Expenses | $112.30MM | $130.61MM | $141.49MM |
| Operating Income | $-58.64MM | $-61.94MM | $-57.70MM |
| Non-Operating Income | $0.07MM | $1.66MM | $1.81MM |
| Interest Expense | $1.07MM | $3.23MM | $3.51MM |
| R&D Expense | $15.40MM | $18.08MM | $17.57MM |
| Income(Loss) | $-58.57MM | $-60.27MM | $-55.89MM |
| Taxes | $0.35MM | $0.57MM | $0.50MM |
| Profit(Loss)* | $-58.92MM | $-60.84MM | $-56.39MM |
| Stockholders Equity | $154.01MM | $118.31MM | $85.81MM |
| Inventory | $14.56MM | $16.74MM | $16.91MM |
| Assets | $193.68MM | $177.78MM | $162.85MM |
| Operating Cash Flow | $-45.08MM | $-37.61MM | $-31.54MM |
| Capital expenditure | $1.32MM | $0.81MM | $1.45MM |
| Investing Cash Flow | $-4.22MM | $-2.01MM | $17.48MM |
| Financing Cash Flow | $2.42MM | $21.40MM | $1.36MM |
| Earnings Per Share** | $-1.59 | $-1.60 | $-1.44 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.